Article

Quantification of the IgG antibody response half-life for hybrid immunity to SARS-CoV-2

2025-07-30

Abstract excerpt

<h4>Background: </h4> A firm understanding of SARS-CoV-2 hybrid immunity is crucial for our ongoing efforts to protect people from severe and fatal disease and assess population vulnerability to emerging novel variants. As many components of the immune response are unobserved and complex to investigate, some ambiguities and unanswered questions remain about hybrid immunity to COVID-19, such as the duration of the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d680e219-b64f-5121-8edc-8190c5d1cee9
DOI: 10.1101/2025.07.29.25332411

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Quantification of the IgG antibody response half-life for hybrid immunity to SARS-CoV-2DOI 10.1101/2025.07.29.25332411Read

Distinguishing SARS-CoV-2 infection and vaccine responses up to 18 months post-infection using nucleocapsid protein and receptor-binding domain antibodiesSemantic proximity Read

Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA VaccinationSemantic proximity Read

Differences in the concentration of anti-SARS-CoV-2 IgG antibodies post-COVID-19 recovery or post-vaccinationSemantic proximity Read

Mechanistic model for booster doses effectiveness in healthy, cancer and immunosuppressed patients infected with SARS-CoV-2Semantic proximity Read

Humoral waning kinetics against SARS-CoV-2 is dictated by disease severity and vaccine platformSemantic proximity Read

Early functional maturation of anti-Spike antibodies predicts SARS-CoV-2 RNA clearance in mild infectionSemantic proximity Read

B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody responseSemantic proximity Read

Low dose mRNA-1273 COVID-19 vaccine generates durable T cell memory and antibodies enhanced by pre-existing crossreactive T cell memorySemantic proximity Read

Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccinationSemantic proximity Read

Broad anti–SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccinationSemantic proximity Read

Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cellsSemantic proximity Read

Antibody kinetics to SARS-CoV-2 at 13.5 months, by disease severitySemantic proximity Read